Lv4
558 积分 2023-11-06 加入
RNAi-based drug design: considerations and future directions
1年前
已完结
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
1年前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
1年前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
1年前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
1年前
已完结
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active Compounds
1年前
已完结
Exploiting temporal aspects of cancer immunotherapy
1年前
已完结
Novel therapies for immune thrombocytopenia
1年前
已完结
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
1年前
已完结
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
1年前
已完结
皖公网安备34019202002308
